The global Refractive Surgery Devices market gathered revenue around USD 170 Million in 2020 and market is set to grow USD 260 Million by the end of 2027 and is estimated to expand at a modest CAGR of 7.0% during the prediction period 2021 to 2027.
Growth Factors:
As a result of the COVID-19 pandemic, consumers have started spending more time on digital devices. The trend of working from home has contributed to an increase in eyestrain, dry eye, and myopia. Furthermore, the growth of the geriatric population has increased the demand for refractive surgery devices. According to the National Institute on Aging (NIA), the geriatric population would be about 72 million individuals by 2030.
Refractive surgery allows a person to be more independent by eliminating the need for spectacles or contact lenses. Consumers have managed their personal spending and emphasized health and wellbeing during the pandemic, which has increased the demand for refractive surgery devices. Whereas the market for refractive surgery devices is being hindered in developing countries due to a shortage of surgical equipment to address refractive defects.
Many companies in the refractive surgery devices sector have moved their focus to the development of advanced refractive surgery devices and are conducting various research programs for the same. As per the World Health Organization, the cost of uncorrected refractive error in terms of direct and indirect global productivity loss is estimated to be USD 269 billion. Myopia is the leading cause of distance refractive error, according to current estimations and demographic trends, and will likely remain so in the future. Therefore, a growing unaddressed patient pool with refractive errors is expected to contribute to the demand for refractive surgery, which is expected to propel the overall market growth.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Refractive Surgery Devices market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Refractive Surgery Devices market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
Report Coverage
Report Scope | Details |
Market Size | USD 260 Million by 2027 |
Growth Rate | CAGR of 7.0% From 2021 to 2027 |
Base Year | 2020 |
Forecast Period | 2021 to 2027 |
Historic Data | 2017 to 2020 |
Report coverage | Growth Factors, Revenue Status, Competitive Landscape, and Future Trends |
Segments Covered | Application, product, end use And Region |
Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
Companies Mentioned | Johnson & Johnson Services, Inc.; Carl Zeiss Meditec AG; Alcon; Bausch & Lomb Incorporated; Quantel Medical; TOPCON CORPORATION; Essilor; NIDEK CO., LTD.; SCHWIND eye-tech-solutions |
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Refractive Surgery Devices market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Regional analysis:
In 2020, North America held the largest share of over 30.2%. High incidence of refractive errors, the presence of significant market players, and the availability of effective reimbursement policies are expected to contribute to the regional market growth. According to the WHO statistics, the number of people aged 65 years and above in the country is expected to reach 78 million by 2035, which will have a positive impact on product demand. Moreover, the implementation of advanced technologies for the development of surgical products is expected to augment the market growth in the region.
Asia Pacific is expected to grow at the highest rate during the forecast period. According to the World Health Organization, the prevalence of myopia will be significantly higher in high-income countries of Asia Pacific. The need for refractive surgery devices is being driven by recent changes in environmental and lifestyle variables such as air pollution, an aging population, and increased use of phones and computers. Several Western companies have capitalized on Asia's rising need for ophthalmic devices. Carl Zeiss Meditec, Ellex, and STAAR Surgical are among the companies that have established a foothold in several regions of Asia and hope to continue expanding throughout the area. Additionally, in December 2019, Dr. Agarwal's Eye Hospital, a leading eye care hospital chain, said that 60 new eye hospitals will be added in India and other South Asian nations over the next two to three years
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Refractive Surgery Devices Market include: Johnson & Johnson Services, Inc.; Carl Zeiss Meditec AG; Alcon; Bausch & Lomb Incorporated; Quantel Medical; TOPCON CORPORATION; Essilor; NIDEK CO., LTD.; SCHWIND eye-tech-solutions
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Highlights of the Report:
Research Methodology
In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Refractive Surgery Devices market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the Refractive Surgery Devices market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Refractive Surgery Devices markets more accurate and reliable.
Secondary Research
It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.
The secondary research sources referred in the process are as follows:
Primary Research
Primary research includes face-to face interviews, online surveys, and telephonic interviews.
Industry participants involved in this research study include:
Key Points Covered in Refractive Surgery Devices market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Refractive Surgery Devices Market, By Application
7.1. Refractive Surgery Devices Market, By Application, 2021-2027
7.1.1. Myopia
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Hyperopia
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Astigmatism
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Presbyopia
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Dry Eyes
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Refractive Surgery Devices Market, By Product
8.1. Refractive Surgery Devices Market, By Product, 2021-2027
8.1.1. Lasers
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Microkeratome
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Aberrometers
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Refractive Surgery Devices Market, By End User
9.1. Refractive Surgery Devices Market, by End User, 2021-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Ambulatory Surgery Centers
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Ophthalmology Clinics
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Refractive Surgery Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Application (2016-2027)
10.1.2. Market Revenue and Forecast, By Product (2016-2027)
10.1.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Application (2016-2027)
10.2.2. Market Revenue and Forecast, By Product (2016-2027)
10.2.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Application (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Product (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Application (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Product (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Application (2016-2027)
10.3.2. Market Revenue and Forecast, By Product (2016-2027)
10.3.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Application (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Product (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Application (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Product (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Application (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Product (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Application (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Product (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.5.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Application (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Product (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Application (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Product (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2027)
Chapter 11. Company Profiles
11.1. Johnson & Johnson Services, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Carl Zeiss Meditec AG
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Alcon
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bausch & Lomb Incorporated
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Quantel Medical
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. TOPCON CORPORATION
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Essilor
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. NIDEK CO., LTD.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. SCHWIND eye-tech-solutions
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms